Reducing Delay in Vaccination of Children: Logistic Barriers
NCT03516682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2019-08-07
Summary
This study will assess the impact of automated reminders for the 6 month and 12 month vaccine visits to increase vaccination in parents experiencing logistic barriers to vaccination.
Conditions
- Communicable Disease
Interventions
- BEHAVIORAL
-
Reminders
Automated reminders for the 6 month and 12 month vaccine visits for parents experiencing logistic barriers to vaccination.
Sponsors & Collaborators
-
University of Colorado, Denver
collaborator OTHER -
Kaiser Permanente
lead OTHER
Principal Investigators
-
Jason Glanz, PhD · Kaiser Permanente
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Month
- Max Age
- 11 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- United States
Study Locations
More Related Trials
-
Study of Adolescent Immunization Recall Systems
NCT01390363 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
Adolescent Vaccination Kiosk Project
NCT01622608 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Reminders to Complete HPV Series
NCT01731496 ·Status: COMPLETED ·Phase: NA
-
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
NCT04496453 ·Status: COMPLETED ·Phase: NA
-
A School Health Center Intervention to Increase Adolescent Vaccination
NCT01595542 ·Status: COMPLETED ·Phase: NA
-
School Located Adolescent Vaccination Study
NCT01719679 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
NCT01439165 ·Status: COMPLETED ·Phase: PHASE4
-
TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients
NCT02511535 ·Status: COMPLETED ·Phase: PHASE4
-
REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children
NCT00447525 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
NCT07203755 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
NCT00355121 ·Status: COMPLETED ·Phase: PHASE2
-
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
NCT03000998 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3
-
Tdap Vaccination for Infant Caregivers
NCT01233401 ·Status: COMPLETED
-
Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
NCT01362322 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
NCT00524732 ·Status: COMPLETED
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE
NCT01546909 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Vaccination on Th2 Immunity in Infancy
NCT02213341 ·Status: TERMINATED
-
Evaluation of Boostrix™10 Years After Previous Booster Vaccination
NCT01147900 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
NCT00263679 ·Status: COMPLETED ·Phase: PHASE3
-
Immunization Schedule Alert Platform
NCT03705455 ·Status: UNKNOWN ·Phase: NA